false 0001850262 0001850262 2026-11-17 2026-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 17, 2026

 

Integral Acquisition Corporation 1

(Exact name of registrant as specified in its charter)

 

Delaware   001-41006   86-2148394
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1330 Avenue of the Americas, 23rd Floor
New York, New York
  10019
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 209-6132

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None. 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

 

 

 

 

 

 

Item 8.01 Other Events

 

Integral Acquisition Corp 1 (the “Company”) was not able to consummate an initial business combination by November 5, 2026 (as extended from November 6, 2025 by the Company’s Board of Directors (the “Board”)) (the “Completion Window”), and pursuant to the Company’s fifth amended and restated certificate of incorporation, the Board has determined to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible subject to lawfully available funds therefor, redeem 100% of the shares of Class A common stock included as part of the units sold in the initial public offering (the “Public Shares”) in consideration of a per-share price, payable in cash, equal to the quotient obtained by dividing (A) the aggregate amount then on deposit in the trust account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), by (B) the total number of Public Shares, which redemption will completely extinguish rights of the holders of such Public Shares (the “Public Shareholders”) (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, dissolve and liquidate, subject in each case to the Company’s obligations under the Delaware General Corporation Law to provide for claims of creditors and other requirements of applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which have expired worthless as the Company failed to complete its initial business combination by the end of the Completion Window.

 

In order to provide for the disbursement of funds from the Company’s trust account, on November 26, 2026, the Company will instruct Continental Stock Transfer & Trust Company (“Continental”), as its trustee, to take all necessary actions to liquidate the securities held in the trust account. Of the $100,000 of interest permitted to be withdrawn for taxes and dissolution expenses, $57,891.80 in interest is available for withdrawal and will be withdrawn to pay a portion of such expenses. The remaining proceeds will be held in a trust operating account while awaiting disbursement to the holders of the Public Shares, at a per share price of approximately $11.61 (the “Redemption Amount”). All other costs and expenses associated with implementing the Company’s plan of dissolution will be funded from proceeds held outside of the trust account. Record holders will receive their pro rata portion of the proceeds of the trust account by delivering their Public Shares to Continental, the Company’s transfer agent. Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount. The Redemption Amount is expected to be paid out on November 27, 2026.

 

On November 17, 2026, the Company issued a press release announcing its liquidation, the Redemption Amount, and the expected date the Company’s securities will cease trading. A copy of the press release is attached as Exhibit 99.1 and incorporated herein.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

The following exhibits are being filed herewith:

 

Exhibit No.   Description of Exhibits
99.1   Press Release, dated November 20, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 20, 2026

 

  INTEGRAL ACQUISITION CORPORATION 1
   
  By: /s/ Enrique Klix
  Name: Enrique Klix
  Title: Chief Executive Officer, Chief Financial Officer and Director

 

2


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

XBRL SCHEMA FILE

XBRL LABEL FILE

XBRL PRESENTATION FILE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: integralacq1_8k_htm.xml